Latest news
- First Nations Health Worker Traineeship (FNHWT) program launches at AHCSA
- AHCSA Sexual Health team present at Aboriginal Sexual Health Workshop, Darwin
- Aboriginal Maternal Infant Care (AMIC) course update
- 13 February 2024: National Apology Day
- Dr Lowitja O’Donoghue AC CBE DSG – 1 August 1932 - 4 February 2024
- Free Mooditj Leadership Training Course, Port Augusta
- Smoking ceremony at AHCSA
- Australia Day 2024
- AHCSA delegation meets with Federal Minister of Health & Aged Care
- SHINE SA brings Mooditj to AHCSA
- AHCSA announces management restructure
- 2023's final face-to-face class concludes at the AHCSA RTO
- AMIC Project Update: Aboriginal Maternal and Infant Care (AMIC) training back on the agenda for 2024
- AHCSA RTO: new CERT III and CERT IV classes commence
- AHCSA and members attend NACCHO annual conference
- Voice to Parliament defeated - self-care resources
- Indigenous bowel-cancer screening
- NACCHO COVID-19 Vaccination Promotion Competition 2023
- Six-week STI/BBV screening program commences at Pika Wiya
- Indigenous Voice to Parliament referendum date announced by Prime Minister Anthony Albanese
- Federal Minister of Health Hon. Mark Butler visits AHCSA
- Oodnadatta desalination plant commences operation
- Drug Alert notice: protonitazene
- NAIDOC Week 2023
- First Nations Philanthropic Funders Working Group focuses on COVID-19 preparation and recovery
17 July 2023
The potent opioid ‘protonitazene’ has been detected in South Australia and could be present in methamphetamine or GHB. Health authorities have already linked it to one death as well as multiple overdoses ( link).
Protonitazene takes the form of a white powder and could be mixed in with other substances. You cannot tell if protonitazene is present just by looking at any given drugs.
For more information, see the Drug Alert PDF below, and stay safe.
Back to all news items